The long-term use of β-blockers in chronic heart failure

Mustafa Aparci; Omer Uz; Zafer Isilak

doi:10.1016/j.ajem.2016.02.051

Switch to Standard View Switch to Enhanced View

The long-term use of β-blockers in chronic heart failure

Mustafa Aparci, MD

Omer Uz, MD

Zafer Isilak, MD

Department of Cardiology, GATA Training and Research Hospital, Istanbul, Turkey

DOI: http://dx.doi.org/10.1016/j.ajem.2016.02.051

Article Info

Purchase this article (PDF Included)

$31.50 USD (24 hour access)

Subscribe to this title

To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

We have read the case report of Patricia et al [1], titled ”Achieving ventricular rate control using metoprolol in beta-blocker naive patients versus patients on chronic beta-blocker therapy” with great interest. The authors reported that intravenous metoprolol for the treatment of atrial fibrillation with rapid ventricular rate was associated with a higher probability treatment response in patients considered β-blocker–naïve compared with patients receiving chronic β-blocker therapy.

To access this article, please choose from the options below

Log In

Register

Create a new account

Purchase access to this article

$31.50 USD|Online access for 24 hours

Claim Access

If you are a current subscriber with Society Membership or an Account Number, claim your access now.

Subscribe to this title

Purchase a subscription to gain access to this and all other articles in this journal.

Institutional Access

Visit ScienceDirect to see if you have access via your institution.

The long-term use of β-blockers in chronic heart failure

Correspondence

Correspondence

Article Info

To access this article, please choose from the options below

Log In

Register

Purchase access to this article

Claim Access

Subscribe to this title

Institutional Access

Article Tools

Related Articles